Overview

* Core Labs ( CLB ) Q2 revenue of $130.2 mln beats analyst expectations, per LSEG data

* Adjusted EPS for Q2 rises 33% sequentially, down 14% yr/yr

* Co repurchased 237,632 shares valued at $2.7 mln, reduced net debt by $9.1 mln

Outlook

* Core Labs ( CLB ) projects Q3 revenue between $127.5 mln and $134.5 mln

* Oilfield reservoir management services provider expects Q3 EPS to be $0.18 to $0.22

* Core anticipates sequentially flat Q3 revenue for Reservoir Descriptions

* Geopolitical issues and softer U.S. land activity present near-term challenges, according to co

* Company sees soft U.S. market offset by international service growth

Result Drivers

* INTERNATIONAL DEMAND - Sequential revenue growth driven by strengthened demand for services and products across international network

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Beat $130.20 $128.80

Revenue mln mln (4

Analysts

)

Q2 EPS $0.22

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 3 "hold" and 1 "sell" or "strong sell"

* The average consensus recommendation for the business support services peer group is "buy."

* Wall Street's median 12-month price target for Core Laboratories Inc ( CLB ) is $13.00, about 2.9% above its July 23 closing price of $12.62

* The stock recently traded at 15 times the next 12-month earnings vs. a P/E of 17 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)